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One hundred forty-one patients were prospectively enrolled in a study of 
contact-tip laser bullectomy at four institutions. Ninety-one have had both 
preoperative and postoperative t sting at 3 months. Nonsmoking patients 
with disabling dyspnea at less than 50 yards and with a forced expiratory 
volume in 1 second of 35% or less were enrolled. Testing included formal 
pulmonary function tests, arterial blood gasses, computed tomographic 
scans, ventilation/perfusion scans, echocardiograms, electrocardiograms, 
6-minute walk testing, transdiaphragmatic pressures, and quality of life 
and dyspnea index questionnaires. A modest 16% improvement was noted 
in forced expiratory volume in 1 second (0.69 to 0.80 L), and there was a 
29% improvement in 6-minute walk distances (655.2 to 846.3 feet). Oxygen 
use was completely discontinued in 16%. Risk factors for mortality included 
age, 6-minute walk distances, low diffusing capacity for carbon monoxide, 
high carbon dioxide tension, and high base excess. Minor improvement was 
judged from the dyspnea index and the Medical Outcome Study Short 
Form-36. Preoperative predictors of good outcome included heterogeneous 
disease, lack of carbon dioxide retention, and no emaciation (weight <40 
kg). Comparison of our results with those in the literature suggests that the 
improvement seen with the contact neodymium:yttrium-aluminum-garnet 
laser is not as good as that provided by the stapled techniques for volume 
reduction. (J Thorac Cardiovasc Surg 1996;112:319-27) 
T he American Lung Association estimates that more than 2 million people in the United States 
had emphysema in 1993 and more than 20,000 
deaths were directly attributed to the disorder. 1 
Excluding the rare patient with giant bullous emphy- 
sema, most patients have been treated nonsurgically 
in the past. Surgery has been described for patients 
From the Divisions of Cardiothoracic Surgery and Pulmonary 
Medicine at Southern Illinois University, Springfield, Ill., a St. 
Louis University, St. Louis, Mo., c University of Pittsburgh, 
Pittsburgh, Pa., a and University of Rochester, Rochester, 
N.Y. b 
Read at the Twenty-first Annual Meeting of The Western 
Thoracic Surgical Association, Coeur d'Alene, Idaho, June 
21-24, 1995. 
Received for publication June 22, 1995; revisions requested Jan. 
18, 1996; revisions received April 15, 1996; accepted for 
publication April 23, 1996. 
Address for reprints: Stephen R, Hazelrigg, MD, P.O. Box 19230, 
800 N. Rutledge, Southern Illinois University, School of 
Medicine, Springfield, IL 62794-9230. 
Copyright © 1996 by Mosby-Year Book, Inc. 
0022-5223/96 $5.00 + 0 12/6/74329 
with diffuse bullous emphysema, but these efforts 
have been hampered either by high rates of compli- 
cations or by the inability to adequately quantitate 
results. 2-9 In 1991, Wakabayashi and associates 1°
began to report success using laser bullectomy for 
this group of patients with diffuse bullous emphy- 
sema. Although their initial results were met with 
resistance, ultimately a demand was created by this 
patient population and interest in the thoracic sur- 
gical community. 
We began our multiinstitutional study in an effort 
to validate or refute the benefit of this surgical 
technique and to try to better define the patient 
population most appropriate for surgical interven- 
tion. 
Patients and methods 
Study methods. One hundred forty-one patients were 
prospectively enrolled in a study of laser bullectomy at 
four institutions between October 1993 and September 
1994. All patents had a forced expiratory volume in 1 
second (FEV1) of 35% or less and disabling dyspnea at 
less than 50 yards with maximal medical therapy. Maximal 
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Fig. 1. Pedunculated bulla that would be ideal for stapled 
excision. 
medical therapy implied the use of metered-dose inhalers, 
oxygen, and steroids, and all patients were evaluated by a 
pulmonary medical specialist to ensure that no other 
medical adjustments were appropriate. Study protocols 
were approved by the institutional review boards and 
informed consent was obtained from each patient. Exclu- 
sion criteria included ventilator dependency, active malig- 
nancy, lack of maximal medical therapy, active infection, 
morbid obesity (>1.5 times ideal body weight), and pul- 
monary hypertension (pulmonary artery systolic pressure 
>60 mm Hg estimated by echocardiography). Pulmonary 
artery pressures greater than 60 mm Hg were selected to 
define significant pulmonary hypertension; this was a 
value arbitrarily selected. All patients underwent preop- 
erative screening, which included formal pulmonary func- 
tion testing with nitrogen washout, arterial blood gases, 
computed tomographic (CT) scans with measurement of
diaphragmatic heights, ventilation/perfusion scans, echo- 
cardiograms and electrocardiograms, 6-minute walk test- 
ing, and quality of life and dyspnea questionnaire, in 
addition to a thorough istory and physical examination. 
All testing was repeated 3 months after laser bullectomy. 
Emphysema was due to tobacco abuse in all but two 
patients (with %-antitrypsin deficiency). Patients with 
localized bulla filling more than one third of the hemitho- 
rax were excluded from this study because they would 
represent a standard indication for surgical therapy. Sta- 
tistical analysis was performed with paired t tests and 
multivariate logistic regression analysis. 
Surgical technique. Laser bullectomy was performed 
thoracoscopically with the use of three or four access ports 
for most cases as previously reported. TM 12 Single lung 
ventilation was achieved with a double-lumen endotra- 
cheal tube. The side chosen for bullectomy was deter- 
mined by the CT scan and the ventilation/perfusion scan. 
Unless the patient had prior trauma or surgery, the side 
with the most severe bullous disease on CT scan and 
worse air trapping on the delayed 5-minute ventilation 
scan was selected. When no dominant side was found the 
right side was chosen. After standard techniques were 
used for access ports, the 10 mm rigid thoracoscope was 
introduced. Although the exact location of the trocar sites 
Fig. 2. Contact probe for Nd:YAG laser (Surgical Laser 
Technology, Valley Forge, Pa.) applied to surface of lung. 
was dependent on individual findings, in general the 
thoracoscope was placed low in the chest. Any bullae that 
were pedunculated were excised by means of the endo- 
scopic stapler (Auto Suture Company Division, United 
States Surgical Corporation, Norwalk, Conn.) (Fig. 1). 
With a grasping forceps to manipulate the lung, the 
neodymium:yttrium-aluminum-garnet (Nd:YAG) laser 
with a contact probe (Surgical Laser Technology, Valley 
Forge, Pa.) was applied to the surface of the lung (Fig. 2). 
Low-power settings (5 to 10 watts) were used and care was 
taken to keep the lung moist to prevent adherence of the 
laser probe to the lung with subsequent tearing. 
By changing the access ites and manipulating the lung, 
we "painted" the majority of the surface of the lung with 
the laser. Bullous tissue readily contracted, effectively 
shrinking the size of the lung. After completion of the 
laser treatment a pleurodesis was generally performed 
either mechanically by abrasion or by the instillation of 
talc. One or two chest tubes were positioned through the 
trocar sites and the lung was reexpanded. An attempt was 
made to look for areas of significant air leak. 
The majority of patients were extubated in the operat- 
ing room or soon thereafter in the intensive care unit. Pain 
management was geared to control pain without sedation 
or respiratory depression. Often hypercarbia was seen in 
the early postoperative period. This was not treated so 
long as oxygenation was adequate and the patient was 
alert and breathing comfortably. 
Results 
One hundred forty-one patients with a mean age 
of 64.7 _+ 7.9 years (40 to 78 years) met the study 
criteria and 91 patients had complete 3-month fol- 
low-up data. Before the operation, oxygen was used 
in 75% (n = 106) and steroids in 42% (n = 59). 
There were no steroid dosages that excluded pa- 
tients from the study and the range of steroid use 
was 5 to 40 rag/day. Preoperatively, 50% of patients 
were limited physically and required a wheelchair if 
The Journal  o f  Thorac ic  and 
Card iovascu lar  Surgery  
Vo lume 112, Number  2 
Hazehigg et al. 3 21 
120 - 
100  - 
80 
O 60 
O 
._ 40 
"O 
20 
i t t t i ] i i I I I I I I I I I t t t t t I 
© 
o/ ° 
© © 
© 
I I I I I I I I I I I I I I I I I I I I I I 
0 20  40  60  80  1 O0 
Preoperative Pdi 
Y=O+1.071"X: R^2=.78 
120 
Fig. 3. Scatter diagram of transthoracic diaphragmatic 
pressures (Pdi). Regression analysis. 
they left home. Results were similar from all partic- 
ipating institutions. For the patients who had a 
stapled resection of a localized pedunculated bulla, 
there was no difference in results as compared with 
the majority of patients who had only laser bullec- 
tomy. 
Overall median hospital stay was 12.0 days (4 to 
193 days), and median stay in the intensive care unit 
was 1.0 day (up to 70 days). Median duration of 
chest tube drainage was 9.0 days (1 to 53 days). 
Many tests were performed before the operation, 
with results again obtained in 3 months. Data on 
these tests are included in the following paragraphs. 
CT scans. In addition to the anatomic informa- 
tion provided by CT scans, distances from the apex 
of the chest to the diaphragm were measured. This 
measurement was believed to be one method of 
quantitating thoracic volume. There were 55 pa- 
tients in whom both preoperative and postoperative 
volume measurements were obtained. The distance 
did decrease on inspiration on the operated side 
(right side, 26.4 cm preoperatively, 23.1 cm postop- 
eratively; left side, 25.0 cm preoperatively, 22.6 
postoperatively). 
Expiratory height decreased significantly (p < 
0.0001), suggesting volume reduction of the hemi- 
thorax had occurred. The mean preoperative height 
was 25 cm on the right and 23.6 cm on the left, and 
Fig. 4. Five-minute washout of ventilation/perfusion scan 
demonstrating a large degree of air trapping. 
at 3 months it had decreased to 22.3 cm on the right 
and 21.6 cm on the left (p < 0.0001). 
Pulmonary function tests. Exhaustive pulmonary 
function tests were performed, with results listed in
Table I. The total lung capacity and residual volume 
were measured by plethysmography. Improvements 
in FEV 1, although modest, did reach statistical 
significance, as did decreases in residual volumes. 
There was a tendency toward lower arterial carbon 
dioxide tension and increased arterial oxygen ten- 
sion at 3 months, but these changes were not 
significant. 
Transthoracic diaphragmatic pressures. This 
pressure proved to be difficult o obtain both before 
and after the operation because of the inability to 
pass the catheter or because of poor patient com- 
pliance. Only 13 patients had preoperative and 
3-month pressure measurements. The mean differ- 
ence between esophageal nd gastric pressures went 
from a mean preoperative value of 50.87 to 67.24 cm 
H20 after the operation (p < 0.07). Nine patients 
had significant improvement in transdiaphragmatic 
pressures, suggesting improved function. One pa- 
tient had no change and three had worse transdia- 
phragmatic pressures (Fig. 3). 
Six-minute walk. The mean preoperative 
6-minute walk times and distance were 4.5 minutes 
and 655.2 feet. Three-month testing revealed in- 
creases to 5.12 minutes (p = 0.0017) and 846.3 feet 
(p < 0.0001). 
Ventilation/perfusion scan. Xenon trapping at 5 
minutes on the operated side was measured and 
3 2 2 Hazelrigg et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
August 1996 
Table I. Pulmonary function tests 
Time of test 
Preop. 3 mo p Value 
FVC 2.29 _+ 0.78 (61.5%) 2.61 _+ 0.81 (71.1%) <0.0001 
FEV1 0.69 _+ 0.21 (24.6%) 0.80 _+ 0.30 (29.2%) <0.0001 
1=EV25/75 0.21 _+ 0.07 (7.1%) 0.26 +_ 0.17 (9.3%) 0.0004 
MVV 26.8 _+ 9.1 (27.4%) 31.1 _+ 12.1 (23.6%) <0.0001 
TLC 8.25 +_ 1.77 (137.5%) 7.71 _+ 1.5 (131.8%) <0.0001 
RV 5.72 -- 1.4 (256%) 4.93 _+ 1.21 (224%) <0.0001 
FRC PL 6.66 _+ 1.5 (188%) 6.05 _+ 1.3 (171%) <0.0001 
DLCO 8.12 +_ 3.5 (39.5%) 8.56 _+ 3.6 (41.9%) 0.0571 
DLCONA 2.38 _+ 0.99 (63.4%) 2.51 _+ 2.03 (61.3%) 0.6030 
FRC N 2 4.56 _+ 1.1 4.52 _+ 1.64 0.6479 
Paco2 42.0 _+ 6.77 mm Hg 41.1 _+ 6.4 mm Hg 0.1171 
Pao2 64.6 _+ 11.2 mm Hg 66.6 _+ 18.5 mm Hg 0.1911 
FVC, Forced vital capacity; FEV1, forced expiratory volume in 1 second; FEV25/Ts, forced expiratory volume 25%/75%; MVV, maximal ventilatory volume; 
TLC, total lung capacity; RV, residual volume; FRC PL, FRC obtained by plethysmography; DLCO, diffusing capacity for carbon monoxide; DLCO/VA, 
diffusing capacity for carbon monoxide by alveolar volume; FRC N2, FRC obtained by nitrogen washout; Paco2, arterial carbon dioxide tension; Pao2, arterial 
oxygen tension. Figures in parentheses are percent predicted. 
demonstrated a ecrease from 50.2% to 43.5% (p = 
0.02). In general the 5-minute washout data along 
with the perfusion scan were used to select he side 
of the surgical procedure. Perfusion scans also 
proved to be significant predictors for improvement 
in FEV 1 (Fig. 4). Those with localized decreased 
perfusion of the upper lobe (<25% of unilateral 
perfusion to upper one third) and more pronounced 
air trapping had the most improvement. 
Oxygen, prednisone requirement, and functional 
state. Seventy-five percent (n = 106) of patients 
were receiving oxygen before the operation. Overall 
16% (n = 17) of these patients were able to 
discontinue supplemental oxygen completely and 
21% (n = 22) were able to reduce their oxygen 
needs, whereas 63% (n = 67) did not show improve- 
ment. 
Steroid dependency did not change significantly, 
going from 42% before the operation to 41% after 
the operation. Although 50% required a wheelchair 
before the operation for minimal activity, 26% 
reported needing a wheelchair 3 months after the 
operation. 
Dyspnea and quality of life assessment. The dys- 
pnea index data are demonstrated in Table II. 13 For 
functional improvement, magnitude of task, and 
magnitude of effort, all demonstrated that more 
than 70% of patients showed improvement. This 
amount of change indicated minor improvement, 
for example, ability to return to work at a reduced 
pace or resumption of some activities with more 
vigor than previously because of improvement in 
shortness of breath. 
The medical outcomes tudy 36-item short form 
health survey (MOS-36) demonstrated that 80% 
believed their breathing was improved since the 
operation.14' 15
Complications. Prolonged air leak (>5 days) was 
the most frequent complication seen in 85 pa- 
tients (55%). Thirty-five of those with leaks for more 
than 5 days had a leak that persisted longer than 2 
weeks (23%). Gastrointestinal problems such as 
ileus were frequently seen and one patient had a 
cecal perforation. Pneumonia developed in four 
(28%) and conversion to thoracotomy, usually for 
large air leaks, occurred in five (3.4%). Two patients 
had cardiac arrhythmias (1.4%) and nine patients 
(5%) required a tracheostomy for prolonged ventila- 
tory support. 
There were eight (5.7%) hospital deaths (death 
within 30 days or >30 days and during surgical 
admission), and five (3.5%) late deaths were noted. 
Hospital mortality was due to pneumonia nd respi- 
ratory failure in five, sepsis in two, and ventricular 
arrhythmia in one. Late deaths were due to un- 
known cause (n = 2), carcinoma (n = 2), and 
progressive respiratory failure (n = 1). One patient 
was identified with mesothelioma at thoracoscopy 
and died after discharge. One patient had a history 
of colon cancer, and although a preoperative 
workup including a bone scan showed no abnormal- 
ities, he died with multiple bone metastases and 
spinal cord compression 2 months after the opera- 
tion. 
Predictors of mortality. Several factors were 
evaluated as predictors of mortality, including oxy- 
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Table II. Laser bullectomy 
Dyspnea index (n = 58) 
No 
Worse change Better 
Functional impairment 10 (17%) 6 (10%) 42 (72%) 
Magnitude of task 8 (14%) 9 (16%) 41 (71%) 
Magnitude of effort 8 (14%) 6 (10%) 44 (76%) 
Table IlL Predictors of mortality 
Mortality Non-mortality 
group group p Value 
Six-minute walk (feet) 356 714 <0.0001 
DLCO (% predicted) 26.5% 38.1% <0.029 
Pco 2 (ram Hg) 48.2 42.5 <0.003 
Base excess 7.7 2.9 <0.0006 
Age (yr) 68.2 63.8 <0.04 
gen use, steroid use, age, walk time and distance, 
forced vital capacity, FEVt, FEV25/75, maximal ven- 
tilatory volume, total lung capacity, residual volume, 
functional residual capacity, diffusing capacity for 
carbon monoxide (DLCO), oxygen tension, and 
carbon dioxide tension. The 6-minute walk distance, 
DLCO, carbon dioxide tension, base excess, and age 
all proved to be statistically significant predictors of 
mortality by multivariate logistic regression analysis 
(Table III). 
Predictors of good results. Defining a good result 
in these patients is often difficult. For the purpose of 
this study, we defined an improvement in FEV 1 of 
greater than 200 ml as a success. This is the defini- 
tion of success for treatment of persons with asthma 
adopted by the American Thoracic Society. Accord- 
ing to this definition, there were only 24 patients 
(19%) for whom success was achieved. In evaluating 
all factors for predictors of success, we found base 
excess, localized decreased perfusion (<25% perfu- 
sion of ipsilateral perfusion to upper one third), and 
weight to be predictors. Base excess in those with 
improvement was 1.02 versus 3.6 in those without 
improvement of FEV1 (p = 0.01). Perfusion scans 
that demonstrated localized decreased perfusion 
(<25% of unilateral perfusion) in the upper lobe 
predicted better esults than those with diffuse dis- 
ease and evenly distributed perfusion. Very low 
preoperative weights (<40 kg) were associated with 
worse outcomes with respect o FEV~. 
Discussion 
Preliminary reports of success with laser bullec- 
tomy by Wakabayashi and associates 1°' 16 served as a 
stimulus for the multiinstitutional prospective study. 
Exhaustive preoperative and postoperative t sting 
were performed in an effort to quantify improve- 
ment and better select groups of patients who may 
benefit. 
The technique of using the contact-tip Nd:YAG 
laser was selected because this was the method that 
was reported as providing the most benefit when this 
trial was begun. 16 Other methods have been used for 
bullectomy, including carbon dioxide laser, free- 
beam Nd:YAG laser, and the argon beam coagula- 
tor. Although these energy forms attempt o pro- 
duce similar effects on the bullous lung tissue, our 
study cannot be directly compared. 
Laser bullectomy was reported in 1991 by Dr. 
Wakabayashi using the carbon dioxide laser in 22 
patients. Only 11 patients had postoperative t sting. 
Benefit was shown in FEV1 as mean values im- 
proved by 43% (0.74 to 1.06 L) and maximal exer- 
cise treadmill times also improved (5.4 to 8.0 min- 
utes). There were two deaths (9.1%), one patient 
required a second thoracoscopy, and three required 
a thoracotomy. Air leaks were prevalent and the 
mean duration of chest ube drainage was 13 days. 1° 
A subsequent report at the American College of 
Surgeons in 1993 reported on 262 patients treated 
with the contact-tip Nd:YAG laser, with all but 
three treated for dyspnea nd diffuse bullous em- 
physema. The mortality rate was reduced to 4.7% 
and average duration of air leak to 10 days. 17 
Data presented at The American Association for 
Thoracic Surgery in April 1993 by Dr. Wakabayashi 
demonstrated some objective improvement. Postop- 
erative values were available in 83 patients (out of 
283), and the FEV~ improved from a mean preop- 
erative value of 24.6% of predicted to 32.9% of 
predicted. Surprisingly the total lung capacity and 
residual volume did not change very much to suggest 
volume reduction. Oxygen requirements were de- 
creased, with more than one half of the patients 
discontinuing oxygen use. Only seven patients 
needed a wheelchair after the operation compared 
with 49 before the operation. No exercise testing 
was reportedJ 6 
Overall our results in terms of pulmonary func- 
tion testing were not as good as these reports. 
Although we had statistically significant improve- 
ments in forced vital capacity, FEV1, and maximal 
ventilatory volume, these changes were of less mag- 
nitude. The FEV 1 improved from 24.6% of pre- 
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dicted to 29.2%. We did, however, see more change 
in residual volume, suggesting some volume reduc- 
tion. Similarly, despite very modest improvement in 
direct pulmonary function data, we were able to 
wean 16% of the patients completely off oxygen, and 
functional exercise capacity improved in most pa- 
tients as evidenced by the 6-minute walk results. 
The mechanisms of improvement in patients with 
diffuse bullous emphysema may be by improved 
respiratory muscle positioning (i.e., diaphragm) ow- 
ing to volume reduction, there may be decreased 
airway resistance owing to decreased intrathoracic 
pressure, and decreased compression of surround- 
ing lung tissue or increased elastic recoil may play 
some role. A report from Brenner and associates is 
on carbon dioxide laser bullectomy suggested that 
more compression predicted better outcome with 
respect o FEV~ and improvement was due to the 
decreased volume of the hemithorax and decreased 
airway resistance. Our results would support hese 
mechanisms because there was a decrease involume 
as measured by residual volumes and the diaphragm 
was higher at expiration as measured by CT scan. 
Our patients also demonstrated less air trapping 
(ventilation/perfusion scan, nitrogen washout,) and 
improved elastic recoil (functional residual capaci- 
ty). 
The 6-minute walk data demonstrated a statisti- 
cally significant improvement of 29%. This must be 
evaluated carefully considering that there was not a 
rigorous preoperative pulmonary rehabilitation pro- 
gram and improvements in this range have been 
seen with pulmonary rehabilitation alone. 19 Al- 
though pulmonary rehabilitation can improve en- 
durance, ithas typically not resulted in improvement 
in pulmonary function tests such as the FEV 1. 
Dyspnea is a very subjective symptom, which we 
tried to quantitate with the dyspnea index and the 
MOS SF-36 questionnaire. The dyspnea index dem- 
onstrated that more than 70% had less dyspnea 
since the surgical procedure, however this was 
graded as a minor improvement. Similarly, the MOS 
SF-36 questionnaire supported subjective improve- 
ment, with 80% of patients indicating their health 
had improved since the operation. 
We attempted to identify preoperative factors 
that suggested increased risk of surgery. DLCO, age, 
6-minute walk, carbon dioxide tension and base 
excess were the only predictive tests seen using 
multivariate logistic regression analysis. Brenner 
and associates 18 also suggested that DLCO was 
predictive of increased risk and this also has been 
shown to be important when other pulmonary re- 
sections are evaluated. 17' 20-22 The 6-minute walk is a 
good test of the physiologic state of the patient. The 
better the patient's ability to perform this test, the 
less likelihood of mortality with the procedure. Both 
carbon dioxide tension and base excess measure the 
same parameters. Excessive carbon dioxide reten- 
tion is associated in our study with mortality. Given 
our present information, we would recommend that 
patients with DLCO less than 30%, a carbon dioxide 
tension greater than 50 mm Hg, or a 6-minute walk 
distance under 350 feet be considered at high risk. 
We presently would not offer surgical therapy to 
these patients but encourage pulmonary rehabilita- 
tion. 
Defining a successful outcome is difficult in this 
group of patients. Many had satisfactory outcomes 
when the dyspnea questionnaires are considered; 
however, their improvements in other parameters 
were not as significant. We chose to select an 
improvement of greater than 200 ml in FEV1 as a 
success. Using this criterion, we were able to find 
several factors that would preoperatively predict a 
satisfactory outcome. The best predictor has been 
localized or heterogeneous di ease as evidenced by 
the ventilation and perfusion scans. Decreased per- 
fusion at the apex (excludes the patients with %- 
antitrypsin deficiency) predicted a good result, as 
did air trapping on the delayed (5-minute) ventila- 
tion scan. Those patients with diffuse disease as 
evidenced by even distribution of perfusion and air 
trapping did not demonstrate as much improve- 
ment. Elevated base excess also predicted a worse 
outcome with respect to improvement in FEV1 and 
appears to be related to a higher operative mortality 
and lower chance of obtaining significant improve- 
ment, although the precise mechanism is unclear. 
Severe preoperative maciation (weight <40 kg) 
likewise was associated with worse results. These 
factors may simply identify patients at the extreme 
end of emphysema, too far along in their disease 
process to benefit from any surgical intervention. 
Given the constellation of variables that predict 
improvement in FEV~ and the factors that predict 
mortality, we can begin to develop a picture of who 
might be considered an ideal candidate for surgical 
intervention. Heterogeneous disease in those pa- 
tients with better endurance characteristics (6- 
minute walk >350 feet, weight >40 kg, and carbon 
dioxide tension <50 mm Hg) would appear to be 
preferred. 
Since the institution of this study there has been 
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interest in performing volume reduction using sta- 
pled techniques. Cooper and coworkers 19 reported 
on 20 patients undergoing sternotomy and bilateral 
volume reduction. Improvements in pulmonary 
function and reduction in residual volume were 
greater than were achieved in our study even when 
taking into consideration bilateral versus unilateral 
procedures. Cooper's group demonstrated a mean 
improvement in FEV1 of 82% in this study. Even 
recently reported results using a unilateral thoraco- 
scopic approach with stapled resection by Keenan 
and colleagues 23 achieved better improvement in 
FEV 1 than outr results with a mean improvement of 
27%. This information suggests to us that volume 
reduction may be more effectively achieved using 
stapled techniques. 
Conclusion 
Laser bullectomy demonstrated some benefit with 
statistically significant improvement in pulmonary 
function tests, reduced lung volumes, better dia- 
phragmatic mobility, reduced air trapping, reduced 
oxygen requirements, and improved exercise ability. 
Although statistical significance was reached, we 
would consider this improvement to be modest and 
suggest hat pulmonary rehabilitation in addition to 
this procedure are responsible. 
The mechanisms for improvement would appear 
to be related to improved function of the diaphragm 
resulting from its more optimal position owing to 
volume reduction, improved elastic recoil, and re- 
duced airway resistance and air trapping. 
The morbidity and mortality for this procedure 
are significant and hence careful selection criteria 
should exist. Given our data we suggest hat patients 
with limited exercise ability, carbon dioxide tension 
retention, and severely reduced DLCO are at too 
great a risk to be routinely offered this procedure. 
Comparative data would suggest that the stapled 
techniques are superior to the contact-tip Nd:YAG 
laser lung reduction. 
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Discussion 
Dr. Paul F. Waters (Los Angeles, Calif.). We owe the 
authors a great debt in providing some hard data on a 
procedure that many of us have suspected for quite some 
time is not particularly successful in the treatment of these 
patients. At our center we have done the volume reduc- 
tion procedure as popularized by Dr. Cooper and his 
group, which I think is probably one of the fastest growing 
procedures in this country. I believe that in a group of 
patients who are carefully selected, as Cooper and asso- 
ciates propose, the results can be duplicated. The St. 
Louis group has published some data suggesting the 
doubling of the FEV 1 in the first 6 months after the 
procedure. The group of patients who present hemselves 
for some kind of emphysema operation are typically very 
ill, very desperate patients who will accept almost any 
procedure that you offer them. We as physicians and 
surgeons who are doing these procedures owe them at 
least the honesty to tell them what procedure is likely to 
give them a good result. This paper demonstrates that 
contact laser bullectomy does not produce good results in 
these desperately ill patients. The price that is paid for 
those bad results is a mortality rate close to 10% plus 
some very serious complications, as Dr. Hazelrigg has 
honestly reported. 
I have a couple of questions, Dr. Hazelrigg. One of 
them concerns pulmonary rehabilitation. In the patients 
who have undergone lung transplantation, whom we see 
regularly and subject to pulmonary rehabilitation, we 
often see a significant improvement in exercise ability, 
particularly the 6-minute walk test, and some of the 
pulmonary function tests. It has been suggested by some 
groups that perhaps the results of this kind of operation, 
including the open volume reduction operation, are at- 
tributable to pulmonary rehabilitation. Dr. Cooper's 
group has shown that additional benefit is provided by the 
operation over and above the benefits of rehabilitation. 
Were your patients offered pulmonary rehabilitation and 
were the results good? Do you have that information? 
Dr. Hazelrigg. We believe strongly that pulmonary 
rehabilitation is an important component. Unfortunately, 
it was not a rigid and rigorous part of our preoperative 
evaluation in this group. Patients were not required to be 
in a pulmonary rehabilitation program. Some of that was 
just logistical, in that more than 75% of the patients in our 
study came from outside a 150-mile radius of our center. 
This made it difficult although not impossible to rigorously 
have them all in pulmonary rehabilitation programs. Ap- 
proximately a third of the patients were reportedly in 
pulmonary rehabilitation programs, although the majority 
of those were programs we are not familiar with in the 
sense that we had any hands-on experience with these 
programs. Many people, including Dr. Cooper, have 
shown improvements in the same range of what we saw 
with this technique simply by the institution of a formal 
rigorous pulmonary rehabilitation program. We believe 
rehabilitation is important, and I am certain it played 
some role in the improvement that we saw in this group of 
patients. At present our belief is that patients who are at 
higher risk because of low walk distances or because of 
lower DLCOs should be enrolled preoperatively in pul- 
monary rehabilitation programs. This is not as necessary 
for those who are in better condition initially. 
Dr. Waters. Dr. Hazelrigg, the volume reduction results 
have suggested that the results are ongoing; in other 
words, at 3 months compared with 6 months there is 
continued improvement up to the 6-month mark, where it 
seems to level off. I know that the follow-up in this group 
of patients has been 3 months, but there must be some 
patients in whom it is longer. Have you noticed any 
improvement beyond the 3-month mark? 
Dr. Hazelrigg. There has been a wide spectrum, but 
overall I would say that whatever improvement has been 
gained by 3 months has remained stable, although there 
are a few exceptions to that. We have also noticed some 
deterioration after 1 year, but we do not have enough 
patients yet for me to make a strong comment on that. 
Dr. Waters. You stopped accruing patients. Does any- 
body in this group of surgeons till perform the proce- 
dure? If so, what are the indications for laser bullectomy 
using this technique? 
Dr. Hazelrigg. I do not believe any of the surgeons that 
participated in this study are using the laser actively, 
certainly not as the primary modality. Some may be using 
it in addition to stapled volume resection for some areas. 
We have actually moved on to using a unilateral approach 
endoscopically with the stapling device to compare di- 
rectly to this group. 
Dr. John Eugene (Torrance, Calif.). Laser bullectomy 
began at The University of California, Irvine, with Dr. 
Wakabayashi. There was a lull in the project from 1991 to 
about 1993, and then we began again by performing laser 
reduction pneumonoplasty as a modification of his origi- 
nal operation. This operation is performed using free- 
beam KTB or Nd:YAG laser radiation for the plication or 
for the contracture of diffuse emphysema. It is coupled 
with resection of areas of discrete mphysema and resec- 
tion of frank bullous disease. Using this approach, we have 
operated on more than 200 lungs. The improvement in
FEV1 approaches 40% for unilateral operations and 80% 
for bilateral operations. Prior work from our laboratory 
has shown that the use of the contact-tip or artificial 
sapphire crystal probe on the tip of a laser fiber causes 
pulling and tearing and actual injury to tissue. Probes 
transmit mostly heat, whereas free-beam laser radiation 
transmits pure laser light to accomplish the reduction. I do 
not know why you chose to use the contact echnique, but 
I am certain that if you were to change to the free-beam 
technique your results would be much better. Dr. Little 
and his group recently reported on a substantial improve- 
ment by using free-beam laser radiation alone without any 
associated resection on their group of 55 patients pre- 
sented at the American Surgical Association. 
Dr. Hazelrigg. I congratulate you on your results. I
really cannot comment because we used the contact mode. 
We selected that type because when we started this study 
back in late 1993 that was the most prevalent and most 
touted method. In fact, I think it was the method that Dr. 
Wakabayashi imself was using at that time, so that we 
were attempting to study the group with what we thought 
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at that time was the best method. Since accruing this 
information we have had others tell us the same thing, 
that the free beam is better. I have no data on which to 
base an opinion. Again, I congratulate you on your results. 
You may well be right. 
Dr. Walter B. Cannon (PaloAlto, Calif.). In this time of 
managed care, are managed care organizations and other 
insurance companies willing to pay for this procedure, 
which is something that they may consider experimental 
surgery? Second, do you do anything with the pleura, such 
as putting talcum powder or anything else on the pleura to 
make the lungs stick, to improve some of the air leak 
problems in the postoperative p riod? 
Dr. Hazelrigg. At least thus far the vast majority of 
payers have paid for this procedure. 
We started out not doing much in the way of pleural 
procedures. We had some patients who returned with 
pneumothorax 1 to 3 weeks after the procedure, and 
after that we started to use pleural procedures, such 
that almost 80% of this group of patients had some sort 
of a pleural procedure. The only ones on whom we 
would not perform a pleural abrasion were those that 
we thought were young enough and potentially candi- 
dates for lung transplantation at a later date. Some had 
talc instilled. The majority had pleural scarification or 
abrasion. 
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